Changes in ornithine decarboxylase (ODC) activity and in polyamine contents of the rat thyroid were studied under various experimental conditions. Methylthiouracil (MTU) treatment produced several-fold increases in the thyroid ODC activity and in the content of putrescine, spermidine and spermine within a week. While serum thyrotropin (TSH) levels increased gradually up to 3 weeks, the content of both putrescine and spermidine tended to reach a plateau after 2 weeks of the goitrogen treatment;
The polyamines, spermidine and spermine and their precursor putrescine, occur ubiquitously in living organisms. The fact that polyamines are found at high concentrations in rapidly growing tissues suggests that these biogenic amines play an important role in the regulation of growth processes (Raina, 1963; Tabor and Tabor, 1964 Cohen, 1971; Bachrach, 1973; Rus-sell, 1973; Raina and Janne, 1975) . Ornithine decarboxylase (ODC, L-ornithine carboxy-lyase, EC 4. 1. 1. 17), which catalyzes the formation of putrescine from L-ornithine, is the first and presumably rate-limiting enzyme in the polyamine biosynthetic pathway in animal tissues. The activity of this enzyme fluctuates rapidly and markedly in response to growth stimuli including hormones (Morris and Fillingame, 1974) . Recently we Suzuki, 1974 and 1975) and others (Richman et al., 1975; Zusman and Burrow, 1975) showed that both endogenous and exogenous thyrotropin (TSH) increased ODC activity in the thyroid gland. We have also shown that rapid thyroid growth induced by 6-methyl-2-thiouracil (MTU) is closely associated with the increased polyamine accumulation in the gland (Matsuzaki and Suzuki, 1975) .
Antithyroid drugs and iodine deficiency produce hypertrophy and hyperplasia of the thyroid in experimental animals (Remington et al., 1937; Astwood et al., 1943; MacKenzie and MacKenzie, 1943) , and involution is induced by discontinuing the drugs and refeeding a high-iodine diet (Wollman and Breitman, 1970) . Althoug thyroid hypertrophy and hyperplasia following goitrogen treatment are evidently responses to the excessive secretion of TSH, some factors are known to modify the goitrogenic action of this pituitary hormone. For instance, methylxanthine derivatives enhance goiter formation when given to rats maintained on a low-iodine diet (LID) or rats fed with submaximal doses of goitrogens (Wolff and Varrone, 1969; Bastomsky, 1971) . In contrast, supplemental iodine can diminish the goitrogenic potency of antithyroid drugs except sulfonamides (Astwood et al., 1943; MacKenzie and MacKenzie, 1943; Milne and Greer, 1962) , without changing the concentration of blood TSH (Abbassi and McKenzie, 1967; Yamada et al., 1976) . Although it is widely accepted that thyroid hormones prevent the hypertrophy and hyperplasia of the thyroid resulting from goitrogen treatment by suppressing TSH secretion, it is also probable that thyroxine depresses the growth response of the thyroid to TSH (Cortell and Rawson, 1944) .
The present experiments were undertaken to investigate whether or not some factors which affect goitrogenic action of TSH also affect polyamine synthesis in the thyroid. and then with ethanol-ether (1: 2 v/v) and dissolved in 1 N sodium hydroxide. The iodine in this NaOH solution was referred to as "organic iodine". Iodine soluble in 5% trichloroacetic acid (TCA) and "organic iodine" in the thyroid were analyzed using a Technicon autoanalyzer.
Serum TSH was determined by NIAMDD radioimmunoassay kits. The concentrations of T3 and T4 in sera were measured by radioimmunoassays (Larsen, 1972; Larsen et al., 1973) . The and-T3 rabbit serum was prepared in this laboratory, using T3 conjugated bovine serum albumin (NBC).
The anti-T4 rabbit serum was supplied by Dr. M. E. Freeman. tsuzaki and Suzuki, 1975) . Appreciable amounts of histamine were found in rat thyroids and it was confirmed that histamine concentration in goitrous rat thyroids was lower than that in intact controls as reported by others (Hoffman and Levey, 1965; Ericson et al., 1972) . Agmatine, cadaverine and 1, 3-diaminopropane were not detected in thyroids from either normal or goitrous rats. Fig. 2 . Effect of MTU treatment and its withdrawal on the content of thyroid polyamines, nucleic acids and "organic iodine". Rats were given MTU at 0.03% in drinking water for 7 days and then the treatment was discontinued. Each assay was done in triplicates, using pooled thyroids from 2 to 5 rats. third day of MTU withdrawal.
There was an increase in the total amounts of both DNA and spermine per gland at 7 days of MTU treatment, with the changes being of smaller magnitude than those in RNA and spermidine. The thyroid content of DNA and spermine decreased only slightly after MTU withdrawal.
The molar ratios of spermidine to spermine were significantly lower than those of the intact controls on the 4th and 7th day of withdrawal.
There was a temporal correlation between the ratio. of spermidine to spermine and that of RNA to DNA (r=0.54, n=18, P < 0.02).
As widely known, goitrogen treatment leads to a reduction in both intrathyroidal and extrathyroidal iodine. The total amount of "organic iodine" was greatly reduced by MTU; it was decreased to less. than 5% of the intact control on the 4th day (Fig. 2) . The thyroid content of TCAsoluble iodine was reduced to a lesser extent by MTU. The thyroidal "organic iodine" reaccumulated significantly as early as on the first day of MTU withdrawal, and was. restored to normal by the 7th day (Table 1) .
Acute effect of excess iodide on thyroid ODC activity in MTU-pretreated rats A single injection of a large dose of KI (1.3mg/100g body weight) resulted in a. prompt decrease in MTU-induced ODC activity (Fig. 3 ). There was a great rise in thyroidal content of TCA-soluble iodine, while "organic iodine" remained depressed. KI injection did not affect the serum levels. of T4, T3 and TSH, and thyroid weight (Table  2) . A negative correlation (r= -0.56, n= 15, P <0.05) between the ODC activity and the concentration of TCA-soluble iodine was disclosed in MTU-pretreated rats. There was no correlation between the enzyme activity and the concentration of "organic iodine". Fig. 3 . Effects of KI injection on thyroid ODC and G6PDH activities, and on intrathyroidal iodine. Rats were pretreated with LID and MTU at 0.03% in drinking water for 10 and 7 days, respectively. KI was injected subcutaneously to animals at the dose of 1.3mg KI per 100g body weight. Asterisks denote significant differences from MTU controls, * P <0.05, ** P <0.01 and *** P <0.001.
Chronic effect of excess iodide on MTUinduced increase in ODC activity
When a large dose of KI (1.3mg/100g body weight/day) in drinking water was given for more than two days to rats maintained on 0.03% MTU, a significant decrease in goiter weight was observed (Table  3 ). The thyroid ODC activity was reduced markedly on the first day of KI treatment and remained depressed thereafter.
These inhibitory effects of KI were observed only rats maintained on MTU but not in rats fed with a regular (iodine-sufficient) diet. The serum levels of TSH, T4 and T3 were little affected by KI in MTU-pretreated rats. The thyroidal concentration of TCA-soluble iodine was depressed significantly by MTU, increased excessively on the first day of KI treatment and then declined progressivel even though KI treatment continued and serum iodine concentrations continued to increase. A negative correlation (r= -0.72, n=13, P < 0.01) between the ODC activity and the concentration of TCA-soluble iodine was observed in those MTU-pretreated rats. There was no significant correlation between the enzyme activity and the concentration of "organic iodine". Neither was there any correlation between the enzyme activity and the elevation in serum iodide concentrations. ments on thyroid glucose 6-phosphate dehydrogenase activity The thyroid glucose 6-phosphate dehydrogenase (G6PDH) is one of the typical enzymes whose activities are augmented by TSH or goitrogen treatment and are depressed by T4 treatment (DeGroot and Dunn, 1964 and . In contrast to-MTU-induced ODC activity, the elevated G6PDH activity was not suppressed either by acute or chronic treatment with KI ( Fig.  3 and Table 3 ). The dehydrogenase activity did not change after 7 days of KI treatment, nor by a larger dose (13mg/100g body weight) of KI.
phylline on the thyroid ODC activity Fig. 4 shows the effects of graded doses of MTU on thyroid weight, ODC activity and serum TSH level. MTU at 0.0003% increased thyroid weight significantly without any change in the ODC activity and serum TSH level. The thyroid ODC activity and TSH level were increased as the dose of MTU increased.
Thyroidal"organic iodine" was reduced to half the normal level in 0.0003% MTU-treated rats.
The simultaneous administration of theophylline at 0.1% with MTU at 0.003% in drinking water produced a larger goiter than that observed with MTU alone. However, theophylline had no effect on thyroid weight when given to rats on an iodinesufficient diet (Table 4) , in agreement with similar observations by Wolff and Varrone (1969) and Bastomsky (1971) . Theophylline alone had no effect on thyroid ODC activity but increased significantly the enzyme activity and decreased the serum T4 level of 0.003% MTU-treated rats without any change in circulating concentrations of TSH and T3. The thyroid ODC activity in 0.03% MTU-treated rats was not increased any further with the concomitant administration of theophylline.
Discussion
Our present studies have shown that thyroid tissue growth and polyamine synthesis in the thyroid change in a roughly parallel manner under various conditions. There is good evidence that TSH is the major regulator of both polyamine synthesis Richman et al., 1975; Zusman and Burrow, 1975) and mitotic activity of follicular cells in the thyroid (Isler, 1974) . However, it is likely that some factors affect the TSHinduced thyroid ODC activation and polyamine accumulation.
We previously suggested that there were some factors, such as Effects of graded doses of MTU on thyroid weight, ODC activity and serum TSH levels. MTU at various concentrations in drinking water was given to rats for 10 days.
Asterisks denote statistically significant differences between treatments and controls, * P<0.05, ** P<0.01 and *** P<0 .001. pituitary hormones other than TSH, which modify the activity of polyamine-biosynthetic enzymes and goiter formation (Matsuzaki and Suzuki, 1975) . In this paper, we showed that thyroidal growth response to a high blood level of TSH in goitrogen-treated animals was modified by circulating thyroid hormones, excess iodine and theophylline, all of which have been shown to affect the thyroid ODC activity.
The administration of a thionamide drug and TSH to hypophysectomized animals results in a greater goiter or a greater mean follicular cell height than that observed in similar animals treated with TSH alone (Rawson and Money, 1949; Halmi and Spirtos, 1954; Alexander and Wolff, 1966) . Rawson (1952) has taken the postition that thionamides cause goiter not only by enhancing TSH secretion but also by potentiating the effect of TSH. Goitrogens induce a several-fold increase in thyroid ODC activity with only a slight increase in serum TSH level a few days after the treatment (Matsuzaki and Suzuki, 1974; Richman et al., 1975) . In thyroid-intact rats, however, large doses of exogenous TSH (1-8 units per animal) induce only a transient increase in thyroid ODC activity (Richman et al., 1975) . These results suggest that thionamide drugs increase thyroid ODC activity not only by enhancing TSH secretion but also by potentiating the effect of TSH to induce thyroid ODC activity, at least in the early phase of their action.
On the first day of MTU withdrawal the thyroid ODC activity was reduced to half the MTU-control level even though the serum TSH level remained unchanged (Table 1). On the 4th day the enzyme activity was decreased to the subnormal level though the serum TSH level was still significantly higher than that of the control. Serum levels of T3 and T4 were much higher than those of MTU-controls on these days. These data together with observations of Yu et al. (1976) that the pretreatment of rats and mice with T3 or T4 blunted the induction of thyroid ODC activity by exogenous TSH, suggest that circulating thyroid hormones may act directly on the thyroid to depress the response of thyroid ODC to TSH.
Iodine in excess amounts is a well-known inhibitor of thyroid functions. Excess iodide impairs the goitrogenic action of thionamide drugs without affecting the serum TSH level (Abbassi and McKenzie, 1967) and T3 and T4 levels (Yamada et al., 1976) . In the present study KI decreased both thyroid weight and ODC activity with little change in serum levels of TSH, T4 and T3. Therefore, the serum levels of these three hormones after KI administration do not account for the observed fall in thyroid ODC activity.
Since the inhibitory action of iodide on the adenylate cyclase responsiveness to TSH is abolished by propylthiouracil, methimazole or perchlorate, it has been postulated that the prior organification of iodide is required in its inhibition (Burke, 1970; Ingbar, 1972; Van Sande et al., 1975; Sherwin and Tong, 1975; Hashizume et al., 1976) . In the present experiment, however, it is unlikely that other iodinated products such as iodotyrosines and iodohistidines within thyroglobulin act as the inhibitor of thyroid ODC activation, for "organic iodine" has remained decreased all through the KI treatment. The inhibitory effect of KI on thyroid ODC activity was observable as early as at 3hr of KI injection (Fig. 3) , while the effect of T4 was evident between 3 and 6hr after injection with a marked decrease in the circulating TSH level (Matsuzaki and Suzuki, 1974 ). An inverse relationship was observed in this experiment between thyroid ODC activity and the intrathyroidal concentration of TCAsoluble iodine, but there was no correlation between the enzyme activity and "organic iodine". These results raise the possibility that a very high concentration of TCAsoluble iodine in the gland acts directly to diminish thyroid ODC responsiveness to Endocrinol. Japon. April 1978 TSH. Although most of the TCA-soluble iodine was reported to be in the form of iodide by Daugeras et al.(1976) , the nature and quantities of coexisting iodinated compound(s) remain to be clarified.
The available information suggests that cyclic AMP is involved in the regulation of ODC activity in various tissues (Beck et al., 1972; Preslock and Hampton, 1973; Russell, 1974 and 1975; Bachrach, 1975) including the thyroid (Zusman and Burrow, 1975) . If thyroid ODC activation is mediated via cyclic AMP, the inhibitory effect of excess iodide on the thyroid ODC would be exerted through the inhibition of the adenylate cyclase-cyclic AMP system. It has repeatedly been shown that iodide dramatically reduces TSH stimulation of adenylate cyclase activity both in vivo and in vitro (Van Sande et al., 1975; Sherwin and Tong, 1975; Hashizume et al., 1976) .
Methylxanthine derivatives are unique in that they have no antithyroid activity but potentiate the action of TSH (Wolff and Varrone, 1969; Bastomsky, 1971 ). Subeffective doses of TSH (or goitrogens) and methylxanthines are synergistic in not only developing goiter but also stimulating ODC activity as shown in the Table 4 . The potentiating effects of theophylline on TSH actions could be explained, at least in part, by its inhibition of cyclic AMP hydrolysis in the thyroid. It is also possible that this drug increases TSH secretion from the pituitary by lowering the serum T4 level or by acting directly on the pituitary. The results of our present study and Wolff and Varrone (1969) , however, show that theophylline has no significant effect on the serum TSH level. This supports that part of the effect of the methylxanthines is due to an induced efficiency in the thyroidal response to TSH, as concluded by the latter authors.
An accelerating effect of theophylline on the disappearance rate of circulating T4 was reported by Bastomsky (1971) who claimed that the decrease in the serum T4 level sensitized thyroid responsiveness to TSH.
Probably this is also the case in our present experiment.
